NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,862 | +8.3% | 2,708 | +7.3% | 0.30% | +13.7% |
| Q2 2023 | $254,621 | +9.7% | 2,523 | 0.0% | 0.26% | +6.1% |
| Q1 2023 | $232,139 | +1.4% | 2,523 | 0.0% | 0.25% | +3.8% |
| Q4 2022 | $228,909 | +6.0% | 2,523 | -1.2% | 0.24% | +10.7% |
| Q2 2022 | $216,000 | -11.8% | 2,553 | -8.6% | 0.22% | -0.5% |
| Q1 2022 | $245,000 | +0.4% | 2,793 | 0.0% | 0.22% | +10.2% |
| Q4 2021 | $244,000 | +7.0% | 2,793 | 0.0% | 0.20% | +6.5% |
| Q3 2021 | $228,000 | -10.6% | 2,793 | 0.0% | 0.18% | -10.7% |
| Q2 2021 | $255,000 | +6.7% | 2,793 | 0.0% | 0.21% | -1.0% |
| Q1 2021 | $239,000 | -9.5% | 2,793 | -0.1% | 0.21% | -15.8% |
| Q4 2020 | $264,000 | +2833.3% | 2,797 | +2697.0% | 0.25% | +1664.3% |
| Q3 2015 | $9,000 | -10.0% | 100 | 0.0% | 0.01% | +75.0% |
| Q2 2015 | $10,000 | 0.0% | 100 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,000 | +11.1% | 100 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $9,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |